搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Helicobacter acinonychis 30S ribosomal protein S16 (rpsP) CSB-YP624202HAAF
CSB-EP624202HAAF
CSB-BP624202HAAF
CSB-MP624202HAAF
CSB-EP624202HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Transcription elongation factor GreA (greA) CSB-YP624203HAAF
CSB-EP624203HAAF
CSB-BP624203HAAF
CSB-MP624203HAAF
CSB-EP624203HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis ATP synthase subunit a (atpB), partial CSB-YP624204HAAF1
CSB-EP624204HAAF1
CSB-BP624204HAAF1
CSB-MP624204HAAF1
CSB-EP624204HAAF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Ribosome maturation factor RimP (rimP) CSB-YP624205HAAF
CSB-EP624205HAAF
CSB-BP624205HAAF
CSB-MP624205HAAF
CSB-EP624205HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Recombination protein RecR (recR) CSB-YP624206HAAF
CSB-EP624206HAAF
CSB-BP624206HAAF
CSB-MP624206HAAF
CSB-EP624206HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP624207HAAF
CSB-EP624207HAAF
CSB-BP624207HAAF
CSB-MP624207HAAF
CSB-EP624207HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis NH (3)-dependent NAD (+) synthetase (nadE) CSB-YP624208HAAF
CSB-EP624208HAAF
CSB-BP624208HAAF
CSB-MP624208HAAF
CSB-EP624208HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Trigger factor (tig) CSB-YP624209HAAF
CSB-EP624209HAAF
CSB-BP624209HAAF
CSB-MP624209HAAF
CSB-EP624209HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Chorismate synthase (aroC) CSB-YP624210HAAF
CSB-EP624210HAAF
CSB-BP624210HAAF
CSB-MP624210HAAF
CSB-EP624210HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis 30S ribosomal protein S21 (rpsU) CSB-YP624211HAAF
CSB-EP624211HAAF
CSB-BP624211HAAF
CSB-MP624211HAAF
CSB-EP624211HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP624212HAAF
CSB-EP624212HAAF
CSB-BP624212HAAF
CSB-MP624212HAAF
CSB-EP624212HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis ATP synthase gamma chain (atpG) CSB-YP624213HAAF
CSB-EP624213HAAF
CSB-BP624213HAAF
CSB-MP624213HAAF
CSB-EP624213HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP624214HAAF
CSB-EP624214HAAF
CSB-BP624214HAAF
CSB-MP624214HAAF
CSB-EP624214HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis tRNA pseudouridine synthase A (truA) CSB-YP624215HAAF
CSB-EP624215HAAF
CSB-BP624215HAAF
CSB-MP624215HAAF
CSB-EP624215HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis S-adenosylmethionine synthase (metK) CSB-YP624216HAAF
CSB-EP624216HAAF
CSB-BP624216HAAF
CSB-MP624216HAAF
CSB-EP624216HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Peptide chain release factor 2 (prfB) CSB-YP624217HAAF
CSB-EP624217HAAF
CSB-BP624217HAAF
CSB-MP624217HAAF
CSB-EP624217HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Na (+)/H (+) antiporter nhaA (nhaA), partial CSB-YP624218HAAF
CSB-EP624218HAAF
CSB-BP624218HAAF
CSB-MP624218HAAF
CSB-EP624218HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Putative nickel-responsive regulator (Hac_0267) CSB-YP624219HAAF
CSB-EP624219HAAF
CSB-BP624219HAAF
CSB-MP624219HAAF
CSB-EP624219HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis 30S ribosomal protein S6 (rpsF) CSB-YP624220HAAF
CSB-EP624220HAAF
CSB-BP624220HAAF
CSB-MP624220HAAF
CSB-EP624220HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP624221HAAF
CSB-EP624221HAAF
CSB-BP624221HAAF
CSB-MP624221HAAF
CSB-EP624221HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>